Evidence map›Paper›PMID 38921894›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Investigating UV-Irradiation Parameters in the Green Synthesis of Silver Nanoparticles from Water Hyacinth Leaf Extract: Optimization for Future Sensor Applications.

Fueangfakan Chutrakulwong, Kheamrutai Thamaphat, Mana Intarasawang

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Synthesis of Silver Nanoparticles by UsingMolecules (Basel, Switzerland) · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fueangfakan ChutrakulwongDivision of Physics, Faculty of Science and Technology, Rajamangala University of Technology Krungthep, Bangkok 10120, Thailand.ORCID 0000-0001-9905-1024
Kheamrutai ThamaphatGreen Synthesis and Application Laboratory, Applied Science and Engineering for Social Solution Research Unit, Department of Physics, Faculty of Science, King Mongkut's University of Technology Thonburi, Bangkok 10140, Thailand.ORCID 0000-0003-0259-2663
Mana IntarasawangDepartment of Science and Technology, Suksanari School, Bangkok 10600, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) can be produced safely and greenly using water hyacinth, an invasive aquatic plant, as a reducing agent. This study aimed to optimize the UV-irradiation parameters for the synthesis of AgNPs from water hyacinth leaf extract. The study varied the reaction time and pH levels and added a stabilizing agent to the mixture. The synthesized AgNPs were characterized using UV-visible spectroscopy (UV-vis), transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and inductively coupled plasma optical emission spectroscopy (ICP-OES). The findings revealed that the optimal conditions for synthesizing AgNPs were achieved by adjusting the pH level to 8.5, adding starch as a stabilizing agent, and exposing the mixture to UV-A radiation for one hour. These conditions resulted in the smallest size and highest quantity of AgNPs. Furthermore, the synthesized AgNP colloids remained stable for up to six months. This study highlights the potential of utilizing water hyacinth as a sustainable and cost-effective reducing agent for AgNP synthesis, with potential applications in pharmaceuticals, drug development, catalysis, and sensing detection.

Indexed as

green synthesissilver nanoparticlessurface plasmon resonanceUV irradiationwater hyacinth

Identifiers

PMID38921894
PMCPMC11206564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.